Inflammopharmacology (Inflammopharmacology)

Publisher : Springer Nature Switzerland AG & Brill

Pharmacology Inflammation Rheumatology

Claim Your Journal Get PRC Visit Website

e-ISSN 1568-5608

p-ISSN 0925-4692

Issue Frequency Quarterly

Impact Factor 5.3

Est. Year 1991

Mobile 41417473600

DOI YES

Language English

APC YES

Impact Factor Assignee Google Scholar

Email editor@inflammopharmacology.com

Journal Descriptions

Inflammopharmacology is a comprehensive resource on all aspects of inflammation and its pharmacological control, emphasizing pain therapy. Compares different inflammatory states and their causes. Examines the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. Offers in-depth coverage of Conditional Pharmacology/Toxicology, Rheumatology, Gastroenterology, Neuro-Inflammation, and Novel Drugs, Natural Products and Nutraceuticals. Places particular emphasis on methods of measurement of clinical response effects of new agents and adverse effects from anti-rheumatic drugs. Focuses on the safety and efficacy of Non-prescription (OTC) and prescription NSAIDs and Analgesics.

Inflammopharmacology (Inflammopharmacology) is :-

International, Peer-Reviewed, Open Access, Refereed, Pharmacology, Inflammation, Rheumatology, Gastroenterology, Neuropharmacology, Toxicology, Pain Management, Drug Safety , Online or Print , Quarterly Journal
UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0925-4692, E-ISSN: 1568-5608, Established: 1991, Impact Factor: 5.3
Provides Crossref DOI
Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE